Tapewire

Nasdaq · USD

LGND

LIGAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
3825
SEC CIK
0000886163
Parsed reports
442

Last 12 months

Inside the activity.

0 purchase rows · 131 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202508
Dec 202508
Jan 202605
Feb 202605
Mar 2026032
Apr 2026011
May 2026014
Jun 2026016
Jul 202608
Aug 2026012
Sep 202606
Oct 202606

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 25, 2021 Filed Jan 28, 2021 00:03 UTC
Korenberg Matthew EEVP,Finance & Strategy and CFO
GrantCommon Stock 2,305 $0.00 $0.00
Disclosure

SEC source: 0000886163-21-000014 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · EVP,Finance & Strategy and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,241

F1 · shares: Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs). Each PSU represented a contingent right to receive one share of the Issuer common stock. The PSUs were originally granted on 05/30/2018 and were eligible to vest based on the Issuer achievement of certain performance objectives during the three-year performance period ending December 31, 2020. On January 25, 2021, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares.

Read SEC document
January 25, 2021 Filed Jan 28, 2021 00:02 UTC
Berkman Charles SSVP, Gen. Counsel & Secretary
Tax withholdingCommon Stock 830 $156.01 $129,488.30
Disclosure

SEC source: 0000886163-21-000013 · edgardoc.xml · nonDerivative · entry 4

Berkman Charles S · CIK 0001392266 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,512

F2 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs.

Read SEC document
January 25, 2021 Filed Jan 28, 2021 00:02 UTC
Berkman Charles SSVP, Gen. Counsel & Secretary
GrantCommon Stock 2,401 $0.00 $0.00
Disclosure

SEC source: 0000886163-21-000013 · edgardoc.xml · nonDerivative · entry 3

Berkman Charles S · CIK 0001392266 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,342

F3 · shares: Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs). Each PSU represented a contingent right to receive one share of the Issuer common stock. The PSUs were originally granted on 05/29/2019 and were eligible to vest based on the Issuer achievement of certain performance objectives during the two-year performance period ending December 31, 2020. On January 25, 2021, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares.

Read SEC document
January 25, 2021 Filed Jan 28, 2021 00:02 UTC
Berkman Charles SSVP, Gen. Counsel & Secretary
Tax withholdingCommon Stock 509 $156.10 $79,454.90
Disclosure

SEC source: 0000886163-21-000013 · edgardoc.xml · nonDerivative · entry 2

Berkman Charles S · CIK 0001392266 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,941

F2 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs.

Read SEC document
January 25, 2021 Filed Jan 28, 2021 00:02 UTC
Berkman Charles SSVP, Gen. Counsel & Secretary
GrantCommon Stock 1,335 $0.00 $0.00
Disclosure

SEC source: 0000886163-21-000013 · edgardoc.xml · nonDerivative · entry 1

Berkman Charles S · CIK 0001392266 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,450

F1 · shares: Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs). Each PSU represented a contingent right to receive one share of the Issuer common stock. The PSUs were originally granted on 05/30/2018 and were eligible to vest based on the Issuer achievement of certain performance objectives during the three-year performance period ending December 31, 2020. On January 25, 2021, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares.

Read SEC document
December 31, 2020 Filed Jan 6, 2021 01:30 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
OtherCommon Stock 223 $84.53 $18,850.75
Disclosure

SEC source: 0000886163-21-000003 · edgardoc.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,310

F1 · kind: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).

Read SEC document
December 08, 2020 Filed Dec 9, 2020 23:12 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 14,657 $0.00 Strike: $10.05 $0.00
Disclosure

SEC source: 0000886163-20-000133 · edgardoc.xml · derivative · entry 3

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 14,657 shares

Expires 2021-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/17/11.

Read SEC document
December 08, 2020 Filed Dec 9, 2020 23:12 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Tax withholdingCommon Stock 1,683 $87.52 $147,296.16
Disclosure

SEC source: 0000886163-20-000133 · edgardoc.xml · nonDerivative · entry 2

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,087

F1 · shares: Represents previously-owned shares delivered to the Issuer in payment of the exercise price of the stock options.

Read SEC document
December 08, 2020 Filed Dec 9, 2020 23:12 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionCommon Stock 14,657 $10.05 $147,302.85
Disclosure

SEC source: 0000886163-20-000133 · edgardoc.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,770

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:41 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $10.05 $0.00
Disclosure

SEC source: 0000886163-20-000124 · edgardoc.xml · derivative · entry 3

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,657

Underlying: Common Stock · 20,000 shares

Expires 2021-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/17/11.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:41 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Tax withholdingCommon Stock 2,458 $81.77 $200,990.66
Disclosure

SEC source: 0000886163-20-000124 · edgardoc.xml · nonDerivative · entry 2

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,113

F1 · shares: Represents previously-owned shares delivered to the Issuer in payment of the exercise price of the stock options.

Read SEC document
November 09, 2020 Filed Nov 11, 2020 00:41 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionCommon Stock 20,000 $10.05 $201,000.00
Disclosure

SEC source: 0000886163-20-000124 · edgardoc.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 224,571

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 02, 2020 Filed Nov 4, 2020 21:19 UTC
Patel SunilDirector
PurchaseCommon Stock 1,000 $82.52 $82,520.00
Disclosure

SEC source: 0000886163-20-000118 · edgardoc.xml · nonDerivative · entry 1

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,190

Read SEC document
August 24, 2020 Filed Aug 25, 2020 23:10 UTC
FOEHR MATTHEW WPresident and COO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 78 $0.00 Strike: $21.92 $0.00
Disclosure

SEC source: 0000886163-20-000099 · edgardoc.xml · derivative · entry 7

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,547

Underlying: Common Stock · 78 shares

Expires 2023-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale(s) reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 03, 2020, in accordance with Rule 10b5-1.

F4 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/15/13.

Read SEC document
August 24, 2020 Filed Aug 25, 2020 23:10 UTC
FOEHR MATTHEW WPresident and COO
SaleCommon Stock 78 $110.89 $8,649.42
Disclosure

SEC source: 0000886163-20-000099 · edgardoc.xml · nonDerivative · entry 5

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,413

F1 · shares: The sale(s) reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 03, 2020, in accordance with Rule 10b5-1.

Read SEC document
August 24, 2020 Filed Aug 25, 2020 23:10 UTC
FOEHR MATTHEW WPresident and COO
Exercise / conversionCommon Stock 78 $21.92 $1,709.76
Disclosure

SEC source: 0000886163-20-000099 · edgardoc.xml · nonDerivative · entry 4

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,491

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale(s) reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 03, 2020, in accordance with Rule 10b5-1.

Read SEC document
August 21, 2020 Filed Aug 25, 2020 23:10 UTC
FOEHR MATTHEW WPresident and COO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 790 $0.00 Strike: $74.42 $0.00
Disclosure

SEC source: 0000886163-20-000099 · edgardoc.xml · derivative · entry 8

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,210

Underlying: Common Stock · 790 shares

Expires 2024-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/12/14.

Read SEC document
August 21, 2020 Filed Aug 25, 2020 23:10 UTC
FOEHR MATTHEW WPresident and COO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 7,225 $0.00 Strike: $14.47 $0.00
Disclosure

SEC source: 0000886163-20-000099 · edgardoc.xml · derivative · entry 6

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,225 shares

Expires 2022-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale(s) reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 03, 2020, in accordance with Rule 10b5-1.

F3 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/09/12.

Read SEC document
August 21, 2020 Filed Aug 25, 2020 23:10 UTC
FOEHR MATTHEW WPresident and COO
SaleCommon Stock 7,225 $112.88 $815,540.66
Disclosure

SEC source: 0000886163-20-000099 · edgardoc.xml · nonDerivative · entry 3

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,413

F1 · shares: The sale(s) reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 03, 2020, in accordance with Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.26 to $114.36, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 21, 2020 Filed Aug 25, 2020 23:10 UTC
FOEHR MATTHEW WPresident and COO
Exercise / conversionCommon Stock 7,225 $14.47 $104,545.75
Disclosure

SEC source: 0000886163-20-000099 · edgardoc.xml · nonDerivative · entry 2

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,638

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale(s) reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 03, 2020, in accordance with Rule 10b5-1.

Read SEC document
August 21, 2020 Filed Aug 25, 2020 23:10 UTC
FOEHR MATTHEW WPresident and COO
Exercise / conversionCommon Stock 790 $74.42 $58,791.80
Disclosure

SEC source: 0000886163-20-000099 · edgardoc.xml · nonDerivative · entry 1

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,413

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 07, 2020 Filed Jul 9, 2020 20:28 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,165 $0.00 Strike: $85.79 $0.00
Disclosure

SEC source: 0000886163-20-000087 · edgardoc.xml · derivative · entry 6

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,226

Underlying: Common Stock · 1,165 shares

Expires 2026-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Grant to reporting person of options to purchase shares of common stock ("Option Shares"), exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/11/16.

Read SEC document
July 07, 2020 Filed Jul 9, 2020 20:28 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,373 $0.00 Strike: $74.42 $0.00
Disclosure

SEC source: 0000886163-20-000087 · edgardoc.xml · derivative · entry 5

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,627

Underlying: Common Stock · 1,373 shares

Expires 2024-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/12/14.

Read SEC document
July 07, 2020 Filed Jul 9, 2020 20:28 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,777 $0.00 Strike: $56.26 $0.00
Disclosure

SEC source: 0000886163-20-000087 · edgardoc.xml · derivative · entry 4

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,421

Underlying: Common Stock · 1,777 shares

Expires 2025-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/10/15.

Read SEC document
July 07, 2020 Filed Jul 9, 2020 20:28 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,373 $74.42 $102,178.66
Disclosure

SEC source: 0000886163-20-000087 · edgardoc.xml · nonDerivative · entry 3

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,571

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 07, 2020 Filed Jul 9, 2020 20:28 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,777 $56.26 $99,974.02
Disclosure

SEC source: 0000886163-20-000087 · edgardoc.xml · nonDerivative · entry 2

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,198

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 07, 2020 Filed Jul 9, 2020 20:28 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionCommon Stock 1,165 $85.79 $99,945.35
Disclosure

SEC source: 0000886163-20-000087 · edgardoc.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,421

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 00:05 UTC
Korenberg Matthew EEVP,Finance & Strategy and CFO
OtherCommon Stock 238 $89.03 $21,188.90
Disclosure

SEC source: 0000886163-20-000083 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · EVP,Finance & Strategy and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,936

F1 · kind: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).

Read SEC document
June 30, 2020 Filed Jul 2, 2020 00:06 UTC
Berkman Charles SSVP, Gen. Counsel & Secretary
OtherCommon Stock 238 $89.03 $21,188.90
Disclosure

SEC source: 0000886163-20-000084 · edgardoc.xml · nonDerivative · entry 1

Berkman Charles S · CIK 0001392266 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,115

F1 · kind: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:46 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,468 $0.00 Strike: $117.58 $0.00
Disclosure

SEC source: 0001104659-20-073020 · a4.xml · derivative · entry 2

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,468

Underlying: Common Stock · 2,468 shares

Expires 2030-06-10

F2 · security: These securities, as represented in Column 5, were acquired by a grant of 2,468 shares approved by the Board of Directors of the Company at the 2020 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time.

F2 · derivative.exercise_date: These securities, as represented in Column 5, were acquired by a grant of 2,468 shares approved by the Board of Directors of the Company at the 2020 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:46 UTC GrantCommon Stock 831 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-073020 · a4.xml · nonDerivative · entry 1

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,431

F1 · security: These securities, as represented in Column 5, include a grant of 831 restricted shares approved by the Board of Directors of the Company at the 2020 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:35 UTC
Aryeh JasonDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 2,468 $0.00 Strike: $117.58 $0.00
Disclosure

SEC source: 0000886163-20-000080 · edgardoc.xml · derivative · entry 4

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,468

Underlying: Common Stock · 2,468 shares

Expires 2030-06-10

F3 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:35 UTC
Aryeh JasonDirector
GrantCommon Stock 831 $0.00 $0.00
Disclosure

SEC source: 0000886163-20-000080 · edgardoc.xml · nonDerivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,034

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:35 UTC
Boyce SarahDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 2,468 $0.00 Strike: $117.58 $0.00
Disclosure

SEC source: 0000886163-20-000079 · edgardoc.xml · derivative · entry 2

Boyce Sarah · CIK 0001629383 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,468

Underlying: Common Stock · 2,468 shares

Expires 2030-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:35 UTC
Boyce SarahDirector
GrantCommon Stock 831 $0.00 $0.00
Disclosure

SEC source: 0000886163-20-000079 · edgardoc.xml · nonDerivative · entry 1

Boyce Sarah · CIK 0001629383 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,262

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:34 UTC
Davis Todd CDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 2,468 $0.00 Strike: $117.58 $0.00
Disclosure

SEC source: 0000886163-20-000078 · edgardoc.xml · derivative · entry 2

Davis Todd C · CIK 0001392029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,468

Underlying: Common Stock · 2,468 shares

Expires 2030-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:34 UTC
Davis Todd CDirector
GrantCommon Stock 831 $0.00 $0.00
Disclosure

SEC source: 0000886163-20-000078 · edgardoc.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,305

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:34 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,468 $0.00 Strike: $117.58 $0.00
Disclosure

SEC source: 0000886163-20-000077 · edgardoc.xml · derivative · entry 2

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,468

Underlying: Common Stock · 2,468 shares

Expires 2030-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:34 UTC GrantCommon Stock 831 $0.00 $0.00
Disclosure

SEC source: 0000886163-20-000077 · edgardoc.xml · nonDerivative · entry 1

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,072

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:33 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,468 $0.00 Strike: $117.58 $0.00
Disclosure

SEC source: 0000886163-20-000076 · edgardoc.xml · derivative · entry 2

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,468

Underlying: Common Stock · 2,468 shares

Expires 2030-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:33 UTC GrantCommon Stock 831 $0.00 $0.00
Disclosure

SEC source: 0000886163-20-000076 · edgardoc.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,208

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:32 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 2,468 $0.00 Strike: $117.58 $0.00
Disclosure

SEC source: 0000886163-20-000075 · edgardoc.xml · derivative · entry 2

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,468

Underlying: Common Stock · 2,468 shares

Expires 2030-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:32 UTC GrantCommon Stock 831 $0.00 $0.00
Disclosure

SEC source: 0000886163-20-000075 · edgardoc.xml · nonDerivative · entry 1

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,768

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:32 UTC
Patel SunilDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 2,468 $0.00 Strike: $117.58 $0.00
Disclosure

SEC source: 0000886163-20-000074 · edgardoc.xml · derivative · entry 2

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,468

Underlying: Common Stock · 2,468 shares

Expires 2030-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2020 Filed Jun 12, 2020 22:32 UTC
Patel SunilDirector
GrantCommon Stock 831 $0.00 $0.00
Disclosure

SEC source: 0000886163-20-000074 · edgardoc.xml · nonDerivative · entry 1

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,190

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2020. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 04, 2020 Filed Jun 5, 2020 20:07 UTC
Berkman Charles SSVP, Gen. Counsel & Secretary
SaleCommon Stock 11,146 $118.59 $1,321,775.16
Disclosure

SEC source: 0000886163-20-000063 · edgardoc.xml · nonDerivative · entry 1

Berkman Charles S · CIK 0001392266 · SVP, Gen. Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,877

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.27 to $118.935, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 13, 2020 Filed Mar 13, 2020 22:33 UTC
FOEHR MATTHEW WPresident and COO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 2,000 $0.00 Strike: $21.92 $0.00
Disclosure

SEC source: 0000886163-20-000029 · edgardoc.xml · derivative · entry 2

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,625

Underlying: Common Stock · 2,000 shares

Expires 2023-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/15/13.

Read SEC document
March 13, 2020 Filed Mar 13, 2020 22:33 UTC
FOEHR MATTHEW WPresident and COO
Exercise / conversionCommon Stock 2,000 $21.92 $43,840.00
Disclosure

SEC source: 0000886163-20-000029 · edgardoc.xml · nonDerivative · entry 1

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,449

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 27, 2020 Filed Feb 28, 2020 01:35 UTC
FOEHR MATTHEW WPresident and COO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,706 $0.00 Strike: $21.92 $0.00
Disclosure

SEC source: 0000886163-20-000027 · edgardoc.xml · derivative · entry 5

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,625

Underlying: Common Stock · 1,706 shares

Expires 2023-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/15/13.

Read SEC document
February 27, 2020 Filed Feb 28, 2020 01:35 UTC
FOEHR MATTHEW WPresident and COO
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 7,225 $0.00 Strike: $14.47 $0.00
Disclosure

SEC source: 0000886163-20-000027 · edgardoc.xml · derivative · entry 4

FOEHR MATTHEW W · CIK 0001237556 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,225

Underlying: Common Stock · 7,225 shares

Expires 2022-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale(s) reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 15, 2019, in accordance with Rule 10b5-1.

F2 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/09/12.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.